Partial Thromboplastin Time, Activated
70 results
1 - 70
activated partial thromboplastin time
Partial Thromboplastin Time, Activated
APTT
telavancin
time
nusinersen
olaratumab
procedure
margetuximab
brigatinib
fruquintinib
tafasitamab
Mitral Stenosis
ripretinib
tivozanib
velaglucerase alfa
tisotumab vedotin
Mitral Insufficiency (Regurgitation)
factor ix (human)
drotrecogin
emicizumab
argatroban
Hemophilia
aprotinin
Thrombophlebitis
Abruptio Placentae
pembrolizumab
hetastarch
anticoagulants
Abnormal Uterine Bleeding
Stroke
deficiency
desirudin
Leukemia, Chronic
Nephrotic Syndrome
tirofiban
Multiple Organ Dysfunction Syndrome
Plethysmography
avapritinib
Disseminated Intravascular Coagulation
anticoagulant therapy
tenecteplase
thrombolytics
occult blood
desmopressin
anistreplase
urokinase
d-Dimer
reteplase
streptokinase
alteplase
Pulmonary Embolism
Prothrombin Time and International Normalized Ratio
Antiphospholipid Antibodies (aPL): Anticardiolipin Antibody, IgG, and IgM; Anti–beta-2 glycoprotein 1, IgG and IgM; Lupus Anticoagulant, IgG and IgM
Procalcitonin
Normal Reference Laboratory Values
hemophilia
myocardial infarction
Medical Abbreviations
Laboratory Critical Findings


